|

Risk Stratification and Prognostic Value of Right Ventricular Dysfunction Screening Using Transthoracic Echocardiography in Acute Pulmonary Embolism

RECRUITINGSponsored by Sohag University
Actively Recruiting
SponsorSohag University
Started2026-06-01
Est. completion2026-11-30
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07647497

Summary

This observational study evaluates right ventricular dysfunction in patients with acute pulmonary embolism using transthoracic echocardiography and assesses its prognostic significance and risk stratification value.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients aged 18 years and older.
* Patients with a confirmed diagnosis of acute pulmonary embolism.
* Patients who underwent transthoracic echocardiographic assessment for right ventricular dysfunction.

Exclusion Criteria:

* Patients younger than 18 years.
* Patients with incomplete clinical data.
* Patients who did not undergo transthoracic echocardiography.

Conditions2

Heart DiseasePulmonary Embolism

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.